Diabetic Neuropathy References

Last updated: 11 November 2024
  1. Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010 Sep;17(9):1113-1123. doi: 10.1111/j.1468-1331.2010.02999.x. PMID: 20402746
  2. Attal N, Bouhassira D. Pharmacotherapy of neuropathic pain: Which drugs, which treatment algorithms?. Pain. 2015 Apr;156(Suppl 1):S104-S114. doi: 10.1097/01.j.pain.0000460358.01998.15. Accessed 13 Dec 2022. PMID: 25789426
  3. Price R, Smith D, Franklin G, et al.. Oral and topical treatment of painful diabetic polyneuropathy: Practice guideline update summary: Report of the AAN Guideline Subcommittee. Neurology. 2022 Jan;98(1):31-43. doi: 10.1212/WNL.0000000000013038. PMID: 34965987
  4. Bril V, England JD, Franklin GM, et al. Evidence-based guideline: Treatment of painful diabetic neuropathy – report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine and Rehabilitation. Neurology. 2011 May;76(20):1758-1765. doi: 10.1212/WNL.0b013e3182166ebe. PMID: 21482920
  5. Diabetes Canada Clinical Practice Guidelines Expert Committee; Bril V, Breiner A, Perkins BA, et al. Neuropathy. Can J Diabetes. 2018 Apr;42(Suppl 1):S217-S221. PMID: 29650100
  6. ElSayed NA, Aleppo G, Aroda VR, et al. 12. Retinopathy, neuropathy, and foot care: Standards of Care in Diabetes—2023. Diabetes Care. 2023 Jan;46(Suppl 1):S203-S215. doi: 10.2337/dc23-S012. Accessed 13 Dec 2022. PMID: 36507636
  7. Feldman EL. Management of diabetic neuropathy. UpToDate. https://www.uptodate.com. 30 Aug 2022.
  8. Feldman EL. Pathogenesis of diabetic polyneuropathy. UpToDate. https://www.uptodate.com. 21 Jul 2022.
  9. Feldman EL. Screening for diabetic polyneuropathy. UpToDate. https://www.uptodate.com. 05 Dec 2022.
  10. Gibbons CH. Diabetic autonomic neuropathy. UpToDate. https://www.uptodate.com. 08 Feb 2021.
  11. James CF, Tripathi S, Karampatou K, et al. Pharmacotherapy of painful diabetic neuropathy: a clinical update. Sisli Etfal Hastan Tip Bul. 2022 Mar;56(1):1-20. doi: 10.14744/SEMB.2021.54670. PMID: 35515975
  12. Javed S, Petropoulos IN, Alam U, et al. Treatment of painful diabetic neuropathy. Ther Adv Chronic Dis. 2015 Jan;6(1):15-28. doi: 10.1177/2040622314552071. PMID: 25553239
  13. National Institute for Health and Care Excellence (NICE). Neuropathic pain in adults: pharmacological management in non-specialist settings. NICE. www.nice.org.uk/. 20 Nov 2013.
  14. Pop-Busui R, Boulton AJM, Feldman EL, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017 Jan;40(1):136-154. doi: 10.2337/dc16-2042. PMID: 27999003
  15. Smith S, Normahani P, Lane T, et al. Prevention and management strategies for diabetic neuropathy. Life (Basel). 2022 Aug;12(8):1185. doi: 10.3390/life12081185. PMID: 36013364
  16. Snyder MJ, Gibbs LM. Treating painful diabetic peripheral neuropathy: an update. Am Fam Physician. 2016 Aug;94(3):227-234. PMID: 27479625
  17. Tauben D, Stacey BR. Pharmacologic management of chronic non-cancer pain in adults. UpToDate. https://www.uptodate.com. 09 Nov 2022.
  18. The Committee for the Guidelines for Pharmacologic Management of Neuropathic Pain of JSPC. Guidelines for the pharmacologic management of neuropathic pain. Shinko Trading Press. 2nd ed. Tokyo; 2016:1-258.
  19. Vijayan R, Jin GK, Cardosa MS, et al. Malaysian guidelines on management of neuropathic pain. 2nd edition. Malaysian Association for the Study of Pain. https://www.masp.org.my/. 2012.
  20. Yavuz DG. Classification, risk factors, and clinical presentation diabetic neuropathy. Diabetic Neuropathy. 2022:1-9. doi: 10.1016/B978-0-12-820669-0.00014-1.
  21. Ziegler D, Keller J, Maler C. et al. German Diabetes Association: clinical practice guidelines on diabetic neuropathy. Exp Clin Endocrinol Diabetes. 2014;122:406-415. doi: 10.1055/s-0034-1366435.
  22. Ziegler D, Tesfaye S, Spallone V, et al. Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: international expert consensus recommendations. Diabetes Res Clin Pract. 2022 Apr;186:109063. doi: 10.1016/j.diabres.2021.109063. PMID: 34547367
  23. Li K, Chen Y, Xie J, et al. How vitamins act as novel agents for ameliorating diabetic peripheral neuropathy: a comprehensive overview. Ageing Research Reviews. 2023 Sep 7;91:1-17. https://www.clinicalkey.com.
  24. Pinzon RT, Schellack N, Matawaran BJ, et al. Clinical recommendations for the use of neurotropic B vitamins (B1, B6, and B12) for the management of peripheral neuropathy: consensus from a multidisciplinary expert panel. J Assoc Physicians India. 2023 Jul;71(7):11-12. doi: 10.59556/japi.71.0290. PMID: 37449697
  25. Pratama S, Lauren BC, Wisnu W. The efficacy of vitamin B12 supplementation for treating vitamin B12 deficiency and peripheral neuropathy in metformin-treated type 2 diabetes mellitus patients: a systematic review. Diabetes Metab Syndr. 2022 Oct;16(10):102634. doi: 10.1016/j.dsx.2022.102634. PMID: 36240684
  26. American Diabetes Association Professional Practice Committee. 12. Retinopathy, neuropathy, and foot care: Standards of Care in Diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S231-S243. doi: 10.2337/dc24-S009. Accessed 21 Dec 2023